Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Repletion in Primary Hyperparathyroidism
NCT01306656Phase 4Completed
- Sponsor
- Columbia University
- Start
- Oct 2011
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d in primary hyperparathyroidism (PHPT) and Vitamin D deficiency (VDD) (2 arms), sponsored by Columbia University. Primary endpoint: Serum Parathyroid Hormone at 6 months. Started Oct 2011; status: completed.
02
Drugs
vitamin d
03
Conditions
primary hyperparathyroidism (PHPT)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01306656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01306656.